Slingshot members are tracking this event:

Allergan's (AGN) Juvederm Vollure XC Approved by FDA for the Correction of Moderate-to-Severe Facial Wrinkles and Folds

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 20, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Juvederm, Vollure Xc, Fda, Approval, Correction, Moderate-to-severe, Facial Wrinkles, Folds